{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:14:09Z","timestamp":1785338049234,"version":"3.55.0"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,11,15]]},"DOI":"10.2169\/internalmedicine.7335-21","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T22:10:42Z","timestamp":1622239842000},"page":"3609-3614","source":"Crossref","is-referenced-by-count":3,"title":["Acute Megakaryoblastic Leukemia Harboring a Subclone Expressing &lt;i&gt;BCR-ABL1&lt;\/i&gt; Fusion Gene Product"],"prefix":"10.2169","volume":"60","author":[{"given":"Emiko","family":"Kashima","sequence":"first","affiliation":[{"name":"Department of Hematology, Suzuka Kaisei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Hematology, Suzuka Kaisei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Suzuka Kaisei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Imai","sequence":"additional","affiliation":[{"name":"Pathology Division, Mie University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Suzuka Kaisei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Suzuka Kaisei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Suzuka Kaisei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Neuendorff NR, Burmeister T, D\u00f6rken B, Westermann J. BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features. Ann Hematol 95: 1211-1221, 2016.","DOI":"10.1007\/s00277-016-2721-z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Soupir CP, Vergilio JA, Dal Cin P, et al. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol 127: 642-650, 2007.","DOI":"10.1309\/B4NVER1AJJ84CTUU"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127: 2391-2405, 2016.","DOI":"10.1182\/blood-2016-03-643544"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shao X, Chen D, Xu P, et al. Primary Philadelphia chromosome positive acute myeloid leukemia: a case report. Medicine 97: e12949, 2018.","DOI":"10.1097\/MD.0000000000012949"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. D\u00f6hner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129: 424-447, 2017.","DOI":"10.1182\/blood-2016-08-733196"},{"key":"6","unstructured":"6. National Comprehensive Cancer Network. Clinical practice guidelines in oncology on acute myeloid leukemia. Version 2 [Internet]. 2021 [cited 2020 Dec 22]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf"},{"key":"7","unstructured":"7. Borowitz MJ, B\u00e9n\u00e9 MC, Harris NL, Porwit A, Matutes E, Arber DA. Acute leukaemia of ambiguous lineage. In: World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Swerdlow SH, Campo E, Harris NL, et al., Eds. International Agency for Research on Cancer, Lyon, 2017."},{"key":"8","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"8. Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 90: 1128-1132, 2005.","journal-title":"Haematologica","ISSN":"https:\/\/id.crossref.org\/issn\/0390-6078","issn-type":"print"},{"key":"9","unstructured":"9. Cuneo A, Ferrant A, Michaux JL, et al. Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features. Haematologica 81: 423-427, 1996."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ismail SI, Naffa RG, Yousef AM, Ghanim MT. Incidence of bcr-abl fusion transcripts in healthy individuals. Mol Med Rep 9: 1271-1276, 2014.","DOI":"10.3892\/mmr.2014.1951"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Song J, Mercer D, Hu X, Liu H, Li MM. Common leukemia- and lymphoma-associated genetic aberrations in healthy individuals. J Mol Diagn 13: 213-219, 2011.","DOI":"10.1016\/j.jmoldx.2010.10.009"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bacher U, Haferlach T, Alpermann T, et al. Subclones with the t(9;22)\/<i>BCR-ABL1<\/i> rearrangement occur in AML and seem to cooperate with distinct genetic alterations. Br J Haematol 152: 713-720, 2011.","DOI":"10.1111\/j.1365-2141.2010.08472.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Neuendorff NR, Hemmati P, Arnold R, et al. <i>BCR-ABL<\/i>+ acute myeloid leukemia: are we always dealing with a high-risk disease? Blood Adv 2: 1409-1411, 2018.","DOI":"10.1182\/bloodadvances.2018015594"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Reboursiere E, Chantepie S, Gac AC, Reman O. Rare but authentic Philadelphia-positive acute myeloblastic leukemia: two case reports and a literature review of characteristics, treatment and outcome. Hematol Oncol Stem Cell Ther 8: 28-33, 2015.","DOI":"10.1016\/j.hemonc.2014.09.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Neuendorff NR, Schwarz M, Hemmati P, et al. <i>BCR-ABL1<\/i>+ acute myeloid leukemia: clonal selection of a <i>BCR-ABL1<\/i>-subclone as a cause of refractory disease with nilotinib treatment. Acta Haematol 133: 237-241, 2015.","DOI":"10.1159\/000368176"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Konoplev S, Yin CC, Kornblau SM, et al. Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia. Leuk Lymphoma 54: 138-144, 2013.","DOI":"10.3109\/10428194.2012.701739"},{"key":"17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12885-019-5265-5","volume":"19","author":"M Piedimonte","year":"2019","unstructured":"17. Piedimonte M, Ottone T, Alfonso V, et al. A rare <i>BCR-ABL1<\/i> transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review. BMC Cancer 19: 50, 2019.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Maiti A, Franquiz MJ, Ravandi F, et al. Venetoclax and <i>BCR-ABL<\/i> tyrosine kinase inhibitor combinations: outcome in patients with Philadelphia chromosome-positive advanced myeloid leukemias. Acta Haematol 143: 567-573, 2020.","DOI":"10.1159\/000506346"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/22\/60_7335-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T03:23:48Z","timestamp":1637378628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/22\/60_7335-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":18,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7335-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"article-number":"7335-21"}}